Data / Form D filings / Ray Therapeutics, Inc.
Ray Therapeutics, Inc.: Form D filings
Ray Therapeutics, Inc., a biotechnology company in San Francisco, CA, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on May 26, 2023, reports $14 million sold of a $100 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE SANSOME STREET, SUITE 3500, San Francisco, CA, 94104
- Phone
- (858) 617-8610
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1920476
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 26, 2023 | New notice | $99,999,956 | $13,999,986 | $85,999,970 | 13 | May 15, 2023 | sec.gov |
| Apr 5, 2022 | New notice | $6,000,000 | $6,000,000 | 15 | May 25, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tiba Aynechi | Director | |
| Dmitry Kuzmin | Director | |
| Sean Ainsworth | Executive Officer, Director | |
| Raymond Camahort | Director | |
| Hannah Chang | Director | |
| Gary Abrams | Director | |
| Paul Bresge | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 22, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ray Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.